Diagnos
Healthcare Software · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7005 Taschereau Blvd Ste 265, Brossard, ...Phone Number
(450) 678-8882Website
www.diagnos.comRevenue
<$5 MillionStock Symbol
ADKIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Diagnos
Diagnos is a leader in artificial intelligence and healthcare technical services, specializing in algorithm development, data analysis, and image processing since 2001. The company aims to assist healthcare professionals in the early detection of critical health issues, particularly focusing on screening services to prevent vision loss and other complications from chronic diseases. Their CARA platform enhances the monitoring of eye diseases, enabling primary care facilities to better manage conditions such as diabetic retinopathy. Diagnos serves a global clientele, including government healthcare systems, and emphasizes cost-effective solutions for improving patient well-being.Explore more
Diagnos Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Diagnos your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Diagnos
Check if Diagnos has recently received funding, and reach out quickly before it becomes old news!
Diagnos, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Diagnos recently announced quarterly report
Funding: Get notified immidiatlly once Diagnos has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Diagnos launches new products
Click to see if Diagnos had a recent Job posting/layoffs
Check out if Diagnos is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Diagnos
Compare insights from companies similar to Diagnos, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Diagnos is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Diagnos is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Diagnos.
Diagnos financials insights
Gather financial insights about Diagnos, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Share Placement
$396K
Diagnos Tech Stack
A closer look at the technologies used by Diagnos
Most Recent Scoops
Facilities Relocation / Expansion
Facilities Relocation/Expansion, Business Development
Executive Move
Board of Directors
Funding
Funding
Promotion
Executive Move
Diagnos has announced that Yves-Stéphane Couture has been promoted from Vice President, Sales to the role of Chief Operating Officer.
Funding
Funding
Diagnos News & Media
DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform
BROSSARD, Quebec, June 16, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that it has submitted a modified and updated application for a Class II medical device licence for its proprietary CARA System platform to Health Canada.DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting
BROSSARD, Quebec, June 12, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, announces a grant of an aggregate number of 1,500,000 stock options to directors and officers of the Corporation.Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform
BROSSARD, Quebec, June 05, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that Emerging Growth Research today released a new flash report on DIAGNOS, highlighting the Company's progress toward key regulatory approvals and the growing commercialization opportunity for its CARA (Computer AssisDIAGNOS to Present at the Emerging Growth Conference on June 10, 2026
DIAGNOS invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference.
Read more news
Top Healthcare Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Diagnos
Sign Up For FreeTo access detailed company insights
Diagnos is a leader in artificial intelligence and healthcare technical services, specializing in algorithm development, data analysis, and image processing since 2001. The company aims to assist healthcare professionals in the early detection of critical health issues, particularly focusing on screening services to prevent vision loss and other co... Read More
